Management Group

A Management Group of experts in clinical and research areas of male reproductive health, public health and health promotion supports the Andrology Australia staff in implementing the activities of the Andrology Australia program.

Professor Robert I McLachlan, AM (Director)

Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research and is Deputy Director of Endocrinology at the Monash Medical Centre. He specialises in the area of male reproductive medicine and has made significant contributions to the research in endocrinology, infertility and andrology. He combines his academic career with active clinical practice as a consultant in these fields.

Rob is a consultant to the World Health Organisation (WHO) on male infertility regulation, is a former President of the Fertility Society of Australia, and former Secretary of the International Society of Andrology.

Rob was also named in the Queen’s Birthday 2016 Honours List as a recipient of the Member of the Order of Australia.

Professor David de Kretser, AC

David was instrumental in establishing Andrology Australia, serving as inaugural Director from 1999 to 2006. He returned to Monash University after his term as the 28th Governor of Victoria, a position he held until April 2011. He continues to serve on the Advisory Board and Management Group of Andrology Australia.

A/Professor Doug Lording

Doug is an endocrinologist and andrologist in private practice at Cabrini Hospital, Melbourne. Doug has a 35-year interest in sexual medicine and testosterone use in men, and is a national expert in erectile dysfunction.

A/Professor Peter Royce

Peter is Director of Urology, Alfred Hospital, Senior Consultant Urologic Surgeon at The Alfred and Cabrini Hospitals in Melbourne, and Adjunct Clinical Associate Professor, Department of Surgery, Monash University.

A/Professor Ben Smith

Ben is based at the School of Public Health and Preventive Medicine at Monash University. He brings 20 years’ experience in the design and evaluation of disease prevention and health promotion strategies, and an extensive history of research into health behaviours and their determinants.

Mr Simon von Saldern, Chief Executive Officer

As CEO, Simon manages the Andrology Australia office and is responsible for overseeing the strategic direction of the program.

Simon’s diverse experience, most recently as General Manager of Development and Business Services at MOVE muscle, bone and joint health, ranges from strategy and planning to communication and stakeholder engagement, sales and marketing, financial, risk and compliance management.

Website by Essendon Creative